Miranda, Anita T.

HRN: 21-52-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
CEFTRIAXONE 1G (VIAL)
10/29/2022
11/04/2022
IVT
2g
OD
Typhoid Fever
Waiting Final Action 
10/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/29/2022
11/04/2022
IVT
500mg
Q8
Typhoid Fever
Waiting Final Action 
11/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/02/2022
11/13/2022
IV
4.5g
Q6
Septic Shock Sec To Intraabdominal Infection
Waiting Final Action 
11/10/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/10/2022
11/13/2022
IVT
4.5gms
Q6
Pyogenic Liver Abscesses
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: